Assyro AI

Orange Book product · Brand (NDA)

LEXETTE

HALOBETASOL PROPIONATE

Brand (NDA)NDA 210566DISCN MAYNE PHARMA

At a glance

May 24, 2018

Approved

Brand (NDA)

Application

Not listed

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 24, 2018

    8 yr 2 mo ago

  2. Today

  3. Patent 10857159 expires

    Listed drug product patent expiration.

    Nov 30, 2036

    in 10 yr 7 mo

  4. Patent 11020407 expires

    Listed drug product patent expiration.

    Nov 30, 2036

    in 10 yr 7 mo

  5. Patent 10857159*PED expires

    Listed listed patent expiration.

    May 30, 2037

    in 11 yr 1 mo

Pharmaceutical detail

Active ingredient

HALOBETASOL PROPIONATE

Strength

0.05%

Dosage form

AEROSOL, FOAM

Route

TOPICAL

TE code

Not listed

Application

NDA 210566

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10857159Nov 30, 2036in 10 yr 7 mo
Product
11020407Nov 30, 2036in 10 yr 7 mo
ProductU-3143
10857159*PEDMay 30, 2037in 11 yr 1 mo
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.